Obermatt
See Similar Stocks →

Croda

LSE:CRDA · GB00BJFFLV09
ChemicalsLarge

360

39
EV / EBIT50
Price / Owner Earnings5
Owner Earnings Yield30
Dividend Yield83
Price/Sales19
EV / Gross Profit52
Price/Book37
Return on Capital14
Cash Return on Capital37
Return on Equity28
EBIT Margin17
Gross Profitability59
Cash Conversion90
Accruals76
Owner Earnings Margin39
Sales growth63
Profit Growth63
Long-Term EPS Growth55
Owner Earnings Growth26
Reinvestment25
Price momentum51
Debt load75
Refinancing34
Debt Payback27
Liquidity45
Analyst ratings67
Opinion Changes50
Price Target Upside73
Market mood81
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Croda clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUK
IndustryChemicals
SizeLarge
TypePublic Company
ExchangeLSE
Founded1925
Employees2,377
Websitecroda.com
ISINGB00BJFFLV09
Last UpdateApr 2, 2026
Indices
FTSE 100 (United Kingdom)FTSE 350 (United Kingdom)FTSE All Shares (United Kingdom)
Themes
Packaging ServicesBio-based and Renewable MaterialsAgriTechLifestyleNutraceuticalGreen Consumer GoodsChemicalConsumerInnovation Management

Description

Croda International Plc (Croda) specializes in the development and supply of innovative and sustainable ingredients. The company operates primarily within the consumer care and life sciences sectors. Business Segments The company operates through C…

Analysis

Middle-of-the-road

Croda International Plc is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 66.2× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 22% yearly growth; analysts expect 10%. The market is pricing in far more than analysts expect: heroic expectations.

The trajectory is moderate and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
82
2023202420252026

All-time high

83

Mar 2026

All-time low

13

Jan 2023

Average rank

46

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
19
11
7
9
Price/Earnings
34
22
14
16
Price/Book
37
27
26
12
Dividend Yield
83
73
48
40
Value (overall)
44
20
11
9

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Croda with its peers
Bioceres Crop
NSQ:BIOX
15
CountryUK
IndustryChemicals
SizeSmall
Full Stock Analysis →
BASF
GER:BAS
38
CountryGermany
IndustryChemicals
SizeXX-Large
Full Stock Analysis →
Givaudan
VTX:GIVN
45
CountrySwitzerland
IndustryChemicals
SizeSmall
Full Stock Analysis →
Bayer CropScience
NSI:BAYERCROP
60
CountryGermany
IndustryChemicals
SizeMedium
Full Stock Analysis →
HEXPOL
STO:HPOL B
52
CountrySweden
IndustryChemicals
SizeMedium
Full Stock Analysis →
Linde
NSQ:LIN
58
CountryUK
IndustryChemicals
SizeXX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →